313 reports of this reaction
1.4% of all GANCICLOVIR reports
#19 most reported adverse reaction
RENAL IMPAIRMENT is the #19 most commonly reported adverse reaction for GANCICLOVIR, manufactured by Bausch & Lomb Incorporated. There are 313 FDA adverse event reports linking GANCICLOVIR to RENAL IMPAIRMENT. This represents approximately 1.4% of all 22,779 adverse event reports for this drug.
Patients taking GANCICLOVIR who experience renal impairment should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RENAL IMPAIRMENT is a less commonly reported adverse event for GANCICLOVIR, but still significant enough to appear in the safety profile.
In addition to renal impairment, the following adverse reactions have been reported for GANCICLOVIR:
The following drugs have also been linked to renal impairment in FDA adverse event reports:
RENAL IMPAIRMENT has been reported as an adverse event in 313 FDA reports for GANCICLOVIR. This does not prove causation, but indicates an association observed in post-market surveillance data.
RENAL IMPAIRMENT accounts for approximately 1.4% of all adverse event reports for GANCICLOVIR, making it a notable side effect.
If you experience renal impairment while taking GANCICLOVIR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.